随着寒冷季节临近，新生儿普遍接种针对呼吸道合胞病毒（RSV）的疫苗可显著减少欧洲婴儿因该病住院的人数。
正文 · 中文译文
新闻编辑室 随着寒冷季节临近，针对普遍呼吸道合胞病毒（RSV）的新生儿免疫接种可显著减少欧洲婴儿住院病例 新闻 2026年10月28日 随着呼吸道合胞病毒（RSV）及其他呼吸道疾病季节的临近，欧洲疾病预防与控制中心（ECDC）的一份新报告表明，针对RSV的新生儿普遍免疫接种可大幅减少冬季期间与该疾病相关的婴儿住院人数。 “在婴儿生命最初几个月保护其免受RSV感染尤为重要，”ECDC部门负责人Bruno Ciancio表示。“而我们正好有工具可以做到这一点。针对RSV的新生儿普遍免疫接种可将幼儿因呼吸道感染住院的风险降低一半以上。” 这些模型评估了为孕产妇提供疫苗接种或直接用抗体对婴儿进行免疫接种的潜力。假设90%的新生儿在出生时接种长效单克隆抗体，模型预测在生命最初两个月内，61%的RSV相关婴儿住院病例可以得到预防。在同一评估中，ECDC估计，孕妇普遍接种疫苗也可使婴儿在出生后最初两个月内因RSV住院的人数显著减少（52%）。 随着欧洲进入秋冬季，呼吸道合胞病毒（RSV）、流感及其他呼吸道感染可能使儿童面临重症风险，同时也给该地区各医疗卫生系统带来额外压力。因此，确保新生儿接种RSV疫苗显得尤为重要。 阅读报告 评估 关于新生儿RSV免疫接种对欧盟/欧洲经济区住院负担影响的多模型评估 2026年10月28日
正文 · 英文原文
Newsroom As the cold season nears, immunisation of newborns against universal RSV could significantly reduce infant hospitalisations across Europe News 28 October 2026 As the season for respiratory syncytial virus (RSV) and other respiratory diseases approaches, a new report from the European Centre for Disease Prevention and Control (ECDC) indicates that universal immunisation of newborns against RSV could substantially reduce hospitalisations among infants linked to the disease during the winter season. ‘Protecting infants from RSV in the first months of their life is particularly important,’ said Bruno Ciancio, ECDC Head of Unit. ‘And we have a tool to do just that. Universal immunisation of newborns against RSV can reduce the risk of hospitalisation due to respiratory infections in young children by more than half.’ The models assessed the potential of providing vaccination to expectant mothers, or immunising infants directly with antibodies. Assuming 90% of newborns are immunised with long-acting monoclonal antibodies at birth, models project that 61% of RSV-related hospitalisations in infants can be prevented in the first two months of life. In the same assessment, ECDC estimates that universal vaccination of pregnant mothers would also lead to substantial reductions in RSV hospitalisation among infants in the first two months of life (52%). As Europe enters the autumn and winter months, RSV, influenza and other respiratory infections can put children at risk of serious illness, while also placing additional pressure on healthcare systems across the region. This makes it all the more important to ensure that newborns are immunised against RSV. Read the report Assessment Multi-model assessment of the impact of newborn RSV immunisation on hospitalisation burden in the EU/EEA 28 October 2026